DODATNA NAVIGACIJA Projekt HRZZ: BrainToxProjekt HRZZ: WNT4EMTKardiovaskularni rizici u školske djece i mladihGenotip-fenotip korelacija u Alportovom sindromu i nefropatiji tankih glomerularnih bazalnih membranaProjekt HRZZ: COPERABiomarkers in schizophreniaProjekt HRZZ: MEFRAProjekt HRZZ: GALADRazvoj ciljane terapije infarkta u novom modelu dijabetesaProjekt HRZZ: BMP1-IsoForProjekt HRZZ: Reprogramiranje citoprotektivnih puteva u mezoteliomuUKF projekti Clinical and biological factors determining severity and activity of chronic graft- versus-host disease after allogeneic hematopoietic stem cell transplantationTrafficking of botulinum toxins in enteric nervous systemCytopathological characterization of the brain in a rat model of sporadic alzheimer’s diseaseProjekt HRZZ: Novi biomarkeri kronične bolesti presatka protiv primateljaProjekt HRZZ: epiSemProjekt HRZZ: BMP6Fe3Projekt HRZZ: epiProProjekt HRZZ: NOFIBROProjekt HRZZ: SMePROFProjekt HRZZ: VAL-DE-ENDProjekt HRZZ: ChildARTHRITISevolveEXPPANDProjekt HRZZ: BRADISCHEMIAProjekt HRZZ: NORAProjektHRZZ: BOBCatProjekt HRZZ: PRE-HYPOProjekt HRZZ – PURPURAPREDICTORSProjekt HRZZ: SepsisFATProjekt HRZZ: MEFCLOProjekt HRZZ: BrainECMProjekt HRZZ: SweetMitochondriaProjekt HRZZ: HepViroTRANSPLANT Početna stranica » Znanost » Istraživanje » Web stranice projekata » Projekt HRZZ: SweetMitochondriaProjekt HRZZ: SweetMitochondriaNaziv projekta: Mitohondrijske podpopulacije i UPRmt u dijabetičkoj kardiomiopatijiAkronim: SweetMitochondriaProject title: Mitochondrial Subpopulations and UPRmt in Diabetic CardiomyopathyPrincipal Investigator (PI): izv. prof. Filip Sedlić, dr. med. Ph.D.Project duration in months: 01.01.2020.-31.03.2024.Project funding: 1.016.000,00 HRK Otvori sve Abstract Mitochondrial dysfunction plays important role in diabetic cardiomyopathy. Mitochondrial unfolded protein response (UPRmt) is one of key mechanisms involved in regulation of proper mitochondrial function. However, the role of UPRmt is not investigated in diabetic cardiomyopathy. This proposal is designed to investigate the role of UPRmt in diabetic cardiomyopathy, focusing on the proposed Yme1L-Oma1 molecular switch.Our preliminary data show that high glucose downregulates Yme1L protein, a trigger and effector of UPRmt. mitoTEMPO, a mitochondria-targeted antioxidant restores Yme1L protein expression. This indicates involvement of ROS in glucose-induced Yme1L downregulation. Preliminary data also show that high glucose accelerates mPTP opening and increases ROS generation.Our experiments will be conducted on isolated cardiomyocytes, diabetic rat hearts and failing human myocardium. The role of UPRmt in diabetes-induced cardiomyopathy will be investigating by several approaches. We will be testing the expression of UPRmt markers and proposed molecular switch that regulates activation of UPRmt by qPCR and western blot. mPTP opening and ROS generation will be tested by confocal microscopy, while cell apoptosis and mitochondrial calcium will be tested by fluorimetric approaches. The mPTP opening time and ROS generation will be also analyzed in previously identified mitochondrial subpopulations, subsarcolemmal and interfibrilar mitochondria. The extent of heart damage will be tested immunopathohistologically. We will apply Yme1L overexpression, Oma1 silencing and mitoTEMPO treatment to restore Yme1L-Oma1 balance, restore UPRmt and ameliorate diabetic cardiomyopathy. Team PI: Filip Sedlić, MD, PhD, Associate ProfessorVesna Kušec, MD, PhD, ProfessorAna Kulić, PhD Assistant ProfessorAna Šepac, MD, PhD, Postdoctoral FellowSunčana Sikirić, Graduate StudentTomo Svaguša, MD, Graduate StudentFran Seiwerth, MD, Graduate Student Publications Svaguša T, Martinić M, Martinić M, Kovačević L, Šepac A, Miličić D, Bulum J, Starčević B, Sirotković-Skerlev M, Seiwerth F, Kulić A, Sedlić F. Mitochondrial unfolded protein response, mitophagy and other mitochondrial quality control mechanisms in heart disease and aged heart. Croat Med J. 2020 Apr 30;61(2):126-138. Otvori svePrijava projekataFinanciranje projekataDomaći projektiMeđunarodni projektiWeb stranice projekata Projekt HRZZ: BrainToxProjekt HRZZ: WNT4EMTKardiovaskularni rizici u školske djece i mladihGenotip-fenotip korelacija u Alportovom sindromu i nefropatiji tankih glomerularnih bazalnih membranaProjekt HRZZ: COPERABiomarkers in schizophreniaProjekt HRZZ: MEFRAProjekt HRZZ: GALADRazvoj ciljane terapije infarkta u novom modelu dijabetesaProjekt HRZZ: BMP1-IsoForProjekt HRZZ: Reprogramiranje citoprotektivnih puteva u mezoteliomuUKF projektiClinical and biological factors determining severity and activity of chronic graft- versus-host disease after allogeneic hematopoietic stem cell transplantationTrafficking of botulinum toxins in enteric nervous systemCytopathological characterization of the brain in a rat model of sporadic alzheimer’s diseaseProjekt HRZZ: Novi biomarkeri kronične bolesti presatka protiv primateljaProjekt HRZZ: epiSemProjekt HRZZ: BMP6Fe3Projekt HRZZ: epiProProjekt HRZZ: NOFIBROProjekt HRZZ: SMePROFProjekt HRZZ: VAL-DE-ENDProjekt HRZZ: ChildARTHRITISevolveEXPPANDProjekt HRZZ: BRADISCHEMIAProjekt HRZZ: NORAProjektHRZZ: BOBCatProjekt HRZZ: PRE-HYPOProjekt HRZZ – PURPURAPREDICTORSProjekt HRZZ: SepsisFATProjekt HRZZ: MEFCLOProjekt HRZZ: BrainECMProjekt HRZZ: SweetMitochondriaProjekt HRZZ: HepViroTRANSPLANTZnanstvenoistraživački radLaboratoriji GlowLab – Laboratorij za regenerativnu neuroznanostIntelektualno vlasništvoObavijesti
Clinical and biological factors determining severity and activity of chronic graft- versus-host disease after allogeneic hematopoietic stem cell transplantationTrafficking of botulinum toxins in enteric nervous systemCytopathological characterization of the brain in a rat model of sporadic alzheimer’s disease
Mitochondrial dysfunction plays important role in diabetic cardiomyopathy. Mitochondrial unfolded protein response (UPRmt) is one of key mechanisms involved in regulation of proper mitochondrial function. However, the role of UPRmt is not investigated in diabetic cardiomyopathy. This proposal is designed to investigate the role of UPRmt in diabetic cardiomyopathy, focusing on the proposed Yme1L-Oma1 molecular switch.Our preliminary data show that high glucose downregulates Yme1L protein, a trigger and effector of UPRmt. mitoTEMPO, a mitochondria-targeted antioxidant restores Yme1L protein expression. This indicates involvement of ROS in glucose-induced Yme1L downregulation. Preliminary data also show that high glucose accelerates mPTP opening and increases ROS generation.Our experiments will be conducted on isolated cardiomyocytes, diabetic rat hearts and failing human myocardium. The role of UPRmt in diabetes-induced cardiomyopathy will be investigating by several approaches. We will be testing the expression of UPRmt markers and proposed molecular switch that regulates activation of UPRmt by qPCR and western blot. mPTP opening and ROS generation will be tested by confocal microscopy, while cell apoptosis and mitochondrial calcium will be tested by fluorimetric approaches. The mPTP opening time and ROS generation will be also analyzed in previously identified mitochondrial subpopulations, subsarcolemmal and interfibrilar mitochondria. The extent of heart damage will be tested immunopathohistologically. We will apply Yme1L overexpression, Oma1 silencing and mitoTEMPO treatment to restore Yme1L-Oma1 balance, restore UPRmt and ameliorate diabetic cardiomyopathy.
PI: Filip Sedlić, MD, PhD, Associate ProfessorVesna Kušec, MD, PhD, ProfessorAna Kulić, PhD Assistant ProfessorAna Šepac, MD, PhD, Postdoctoral FellowSunčana Sikirić, Graduate StudentTomo Svaguša, MD, Graduate StudentFran Seiwerth, MD, Graduate Student
Svaguša T, Martinić M, Martinić M, Kovačević L, Šepac A, Miličić D, Bulum J, Starčević B, Sirotković-Skerlev M, Seiwerth F, Kulić A, Sedlić F. Mitochondrial unfolded protein response, mitophagy and other mitochondrial quality control mechanisms in heart disease and aged heart. Croat Med J. 2020 Apr 30;61(2):126-138.
Projekt HRZZ: BrainToxProjekt HRZZ: WNT4EMTKardiovaskularni rizici u školske djece i mladihGenotip-fenotip korelacija u Alportovom sindromu i nefropatiji tankih glomerularnih bazalnih membranaProjekt HRZZ: COPERABiomarkers in schizophreniaProjekt HRZZ: MEFRAProjekt HRZZ: GALADRazvoj ciljane terapije infarkta u novom modelu dijabetesaProjekt HRZZ: BMP1-IsoForProjekt HRZZ: Reprogramiranje citoprotektivnih puteva u mezoteliomuUKF projektiClinical and biological factors determining severity and activity of chronic graft- versus-host disease after allogeneic hematopoietic stem cell transplantationTrafficking of botulinum toxins in enteric nervous systemCytopathological characterization of the brain in a rat model of sporadic alzheimer’s diseaseProjekt HRZZ: Novi biomarkeri kronične bolesti presatka protiv primateljaProjekt HRZZ: epiSemProjekt HRZZ: BMP6Fe3Projekt HRZZ: epiProProjekt HRZZ: NOFIBROProjekt HRZZ: SMePROFProjekt HRZZ: VAL-DE-ENDProjekt HRZZ: ChildARTHRITISevolveEXPPANDProjekt HRZZ: BRADISCHEMIAProjekt HRZZ: NORAProjektHRZZ: BOBCatProjekt HRZZ: PRE-HYPOProjekt HRZZ – PURPURAPREDICTORSProjekt HRZZ: SepsisFATProjekt HRZZ: MEFCLOProjekt HRZZ: BrainECMProjekt HRZZ: SweetMitochondriaProjekt HRZZ: HepViroTRANSPLANT